These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 19022520)
1. Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer. Malentacchi F; Simi L; Nannelli C; Andreani M; Janni A; Pastorekova S; Orlando C Lung Cancer; 2009 Jun; 64(3):271-6. PubMed ID: 19022520 [TBL] [Abstract][Full Text] [Related]
2. Splicing variants of carbonic anhydrase IX in bladder cancer and urine sediments. Malentacchi F; Vinci S; Della Melina A; Kuncova J; Villari D; Giannarini G; Nesi G; Selli C; Orlando C Urol Oncol; 2012; 30(3):278-84. PubMed ID: 20875751 [TBL] [Abstract][Full Text] [Related]
3. Response of CAIX and CAXII to in vitro re-oxygenation and clinical significance of the combined expression in NSCLC patients. Ilie M; Hofman V; Zangari J; Chiche J; Mouroux J; Mazure NM; Pouysségur J; Brest P; Hofman P Lung Cancer; 2013 Oct; 82(1):16-23. PubMed ID: 23910904 [TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer. Simi L; Venturini G; Malentacchi F; Gelmini S; Andreani M; Janni A; Pastorekova S; Supuran CT; Pazzagli M; Orlando C Lung Cancer; 2006 Apr; 52(1):59-66. PubMed ID: 16513206 [TBL] [Abstract][Full Text] [Related]
5. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer. Ilie M; Mazure NM; Hofman V; Ammadi RE; Ortholan C; Bonnetaud C; Havet K; Venissac N; Mograbi B; Mouroux J; Pouysségur J; Hofman P Br J Cancer; 2010 May; 102(11):1627-35. PubMed ID: 20461082 [TBL] [Abstract][Full Text] [Related]
6. Diverging prognostic impacts of hypoxic markers according to NSCLC histology. Andersen S; Eilertsen M; Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM Lung Cancer; 2011 Jun; 72(3):294-302. PubMed ID: 21075472 [TBL] [Abstract][Full Text] [Related]
7. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes. Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818 [TBL] [Abstract][Full Text] [Related]
8. Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype. Barathova M; Takacova M; Holotnakova T; Gibadulinova A; Ohradanova A; Zatovicova M; Hulikova A; Kopacek J; Parkkila S; Supuran CT; Pastorekova S; Pastorek J Br J Cancer; 2008 Jan; 98(1):129-36. PubMed ID: 18026188 [TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438 [TBL] [Abstract][Full Text] [Related]
10. [Expression of carbonic anhydrase IX in NSCLC and its relationship with VEGF and Ki67 expression]. Zhao X; Liu X; Guo W; Li X Zhongguo Fei Ai Za Zhi; 2010 Sep; 13(9):861-6. PubMed ID: 20840814 [TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer. Mees G; Vangestel C; Dierckx R; Pauwels P; Van Meerbeeck J; Van de Wiele C Cancer Biother Radiopharm; 2010 Apr; 25(2):149-54. PubMed ID: 20423227 [TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX in early-stage non-small cell lung cancer. Kim SJ; Rabbani ZN; Vollmer RT; Schreiber EG; Oosterwijk E; Dewhirst MW; Vujaskovic Z; Kelley MJ Clin Cancer Res; 2004 Dec; 10(23):7925-33. PubMed ID: 15585626 [TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma. Phuoc NB; Ehara H; Gotoh T; Nakano M; Kamei S; Deguchi T; Hirose Y Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901 [TBL] [Abstract][Full Text] [Related]
16. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Le QT; Chen E; Salim A; Cao H; Kong CS; Whyte R; Donington J; Cannon W; Wakelee H; Tibshirani R; Mitchell JD; Richardson D; O'Byrne KJ; Koong AC; Giaccia AJ Clin Cancer Res; 2006 Mar; 12(5):1507-14. PubMed ID: 16533775 [TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. Leibovich BC; Sheinin Y; Lohse CM; Thompson RH; Cheville JC; Zavada J; Kwon ED J Clin Oncol; 2007 Oct; 25(30):4757-64. PubMed ID: 17947723 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia. Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155 [TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker. Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047 [TBL] [Abstract][Full Text] [Related]
20. High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma. Brockton NT; Klimowicz AC; Bose P; Petrillo SK; Konno M; Rudmik L; Dean M; Nakoneshny SC; Matthews TW; Chandarana S; Lau HY; Magliocco AM; Dort JC Oral Oncol; 2012 Jul; 48(7):615-22. PubMed ID: 22366443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]